Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-12-27
pubmed:abstractText
The purpose of the current study was to assess whether [18F]fluorodeoxyglucose positron emission tomography (FDG-PET) provides incremental value (e.g., additional information on lymph node involvement or the presence of distant metastases) compared with computed tomography (CT) in patients with esophageal carcinoma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0008-543X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
148-56
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15558794-Adult, pubmed-meshheading:15558794-Aged, pubmed-meshheading:15558794-Aged, 80 and over, pubmed-meshheading:15558794-Carcinoma, pubmed-meshheading:15558794-Combined Modality Therapy, pubmed-meshheading:15558794-Decision Making, pubmed-meshheading:15558794-Esophageal Neoplasms, pubmed-meshheading:15558794-Female, pubmed-meshheading:15558794-Fluorodeoxyglucose F18, pubmed-meshheading:15558794-Humans, pubmed-meshheading:15558794-Male, pubmed-meshheading:15558794-Middle Aged, pubmed-meshheading:15558794-Neoplasm Metastasis, pubmed-meshheading:15558794-Neoplasm Staging, pubmed-meshheading:15558794-Positron-Emission Tomography, pubmed-meshheading:15558794-Prognosis, pubmed-meshheading:15558794-Radiopharmaceuticals, pubmed-meshheading:15558794-Retrospective Studies, pubmed-meshheading:15558794-Tomography, X-Ray Computed
pubmed:year
2005
pubmed:articleTitle
The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
pubmed:affiliation
Department of General Surgical Science (Surgery I), Gunma University Graduate School of Medicine, Maebashi, Japan. hiroyuki@po.wind.ne.jp
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't